Universität zu Köln

2022

Kibel, Adam S., Gleave, Martin, Brookman-May, Sabine D., Kim, Won, Evans, Christopher P., Efstathiou, Eleni, Kantoff, Philip W., Ross, Ashley, Shore, Neal D., Briganti, Alberto, Hadaschik, Boris A., Heidenreich, Axel, Rooney, Oliver Brendan, Tian, Shaozhou Ken, Wetherhold, Lisa, Xu, Weichun, Parsons, J. Kellogg, Yeruva, Kesav and Taplin, Mary-Ellen (2022). PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients (pts) with localized or locally advanced high-risk prostate cancer (PC). J. Clin. Oncol., 40 (6). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

2020

Taplin, Mary-Ellen, Gleave, Martin, Evans, Christopher P., Efstathiou, Eleni, Kantoff, Philip W., Ross, Ashley, Shore, Neal D., Briganti, Alberto, Hadaschik, Boris A., Heidenreich, Axel, Rooney, Oliver Brendan, Tian, Shaozhou Ken, Wetherhold, Lisa, Xu, Weichun, Cheng, Shinta, Brookman-May, Sabine Doris, Lopez-Gitlitz, Angela and Kibel, Adam S. (2020). PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase III trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC). J. Clin. Oncol., 38 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

2018

Beer, Tomasz M., Chowdhury, Simon, Saad, Fred, Shore, Neal D., Higano, Celestia S., Iversen, Peter, Fizazi, Karim, Miller, Kurt, Heidenreich, Axel, Kim, Choung Soo, Phung, De, Barrus, Jeffrey Kent, Nikolayeva, Natalia, Krivoshik, Andrew, Waksman, Javier and Tombal, Bertrand F. (2018). Hepatic effects assessed by review of safety data in enzalutamide castration-resistant prostate cancer (CRPC) trials. J. Clin. Oncol., 36 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Siemens, D. Robert, Klotz, Laurence, Heidenreich, Axel, Chowdhury, Simon, Villers, Arnauld, Baron, Benoit, van Os, Steve, Hasabou, Nahla, Wang, Fong, Lin, Ping and Shore, Neal D. (2018). Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial. J. Urol., 199 (1). S. 147 - 155. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1527-3792

2017

Heidenreich, Axel, Chowdhury, Simon, Klotz, Laurence, Siemens, David Robert, Villers, Arnauld, Ivanescu, Cristina, Holmstrom, Stefan, Baron, Benoit, Wang, Fong, Lin, Ping and Shore, Neal D. (2017). Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial. Eur. Urol., 71 (4). S. 534 - 543. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1873-7560

2016

Chowdhury, Simon, Shore, Neal D., Villers, Arnauld, Klotz, Laurence, Siemens, D. Robert, Baron, Benoit, van Os, Steve, Hasabou, Nahla, Wang, Fong, Forer, David and Heidenreich, Axel (2016). Efficacy and safety of enzalutamide vs bicalutamide in European and North American men participating in the TERRAIN trial. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Siemens, D. Robert, Klotz, Laurence, Heidenreich, Axel, Chowdhury, Simon, Villers, Arnauld, Baron, Benoit, Van Os, Steve, Hasabou, Nahla, Brown, Scott, Wang, Fong, Forer, David and Shore, Neal D. (2016). EFFICACY AND SAFETY OF ENZALUTAMIDE VERSUS BICALUTAMIDE IN YOUNGER AND OLDER PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN THE TERRAIN TRIAL. Asia-Pac. J. Clin. Oncol., 12. S. 117 - 118. HOBOKEN: WILEY-BLACKWELL. ISSN 1743-7563